Abstract Details

Title A Literature Review of the Economic Burden of Fragile X Syndrome

Topic Child Neurology and Developmental Neurology

Presentation(s) P3 - (-)

Poster/Presentation
Number 319

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Patricia Sacco, MPH PRESENTER	No disclosure on file
	No disclosure on file
Leslie Leahy, PhD (Elan Pharmaceuticals)	Dr. Leahy has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Vigil Neuroscience. Dr. Leahy has stock in Ovid Therapeutics.
	No disclosure on file

��ɫ����